Impact of an Infusion Therapy Nursing Expert Service on Length of Stay and Clinical Results of Venous Access Devices

Impact of an Infusion Therapy Nursing Expert Service on Length of Stay, Clinical Results of Venous Access Devices and Satisfaction on Patients With Long Intravenous Therapy Prescription.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01548365

Acronym

ETI

Enrollment

Registered

2012-03-08

Start date

2012-03-31

Completion date

2012-12-31

Last updated

2013-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Prolonged Intravenous Therapy

Keywords

Nursing Services, Catheterization, Central Venous, Catheters Indwelling, Catheterization, Peripheral

Brief summary

The purpose of this study is to determine whether an infusion therapy nursing expert service is effective in decreasing hospital length of stay, improving the clinical results of venous access devices and increasing patient satisfaction with venous access.

Interventions

OTHERInfusion therapy nursing expert service

The ITNE will assess the patient and treatment characteristics and use an evidence based decision making algorithm for the selection of the most suitable VAD. If the VAD needed is a PICC or a midline ITNE will place it following hospital's protocols. If needed, ITNE will also educate and support patients and next of keens in the maintenance of the device at home. If other devices such as peripheral catheters, central venous catheters (jugular or subclavian) or venous subcutaneous reservoirs are the preferable VADs for patients and treatment conditions, ITNE will work together with health professionals in charge of patients to activate the usual procedures to place the according device.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Require an estimated long prescription of intravenous treatment. These treatments may be of fluid therapy, pharmacological, nutritional or hemotherapy. * Estimation of 7 days or more of continuous intravenous therapy. * Estimation of an intermittent intravenous therapy of less than a week, but on a monthly basis or less and a total estimated duration superior to 3 months. * Be patient at Araba University Hospital

Exclusion criteria

* To have a central venous catheter indwelled * MRSA (Methicillin Resistant Staphylococcus Aureus) * Younger than 18 years old

Design outcomes

Primary

Measure	Time frame
Hospital Length of Stay	3 months

Secondary

Measure	Time frame
Venous Access Devices reaching end of treatment	3 months
Incidence of complications derived from VAD	3 months
Patients receiving intravenous therapy at home	3 months
Patient satisfaction with VAD	3 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026